A detailed history of Great West Life Assurance CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 26,101 shares of CRL stock, worth $4.98 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,101
Previous 22,536 15.82%
Holding current value
$4.98 Million
Previous $6.11 Million 11.68%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$206.39 - $268.73 $735,780 - $958,022
3,565 Added 15.82%
26,101 $5.39 Million
Q1 2024

May 13, 2024

SELL
$203.52 - $273.43 $293,882 - $394,832
-1,444 Reduced 6.02%
22,536 $6.11 Million
Q4 2023

Feb 13, 2024

BUY
$164.52 - $238.84 $399,948 - $580,620
2,431 Added 11.28%
23,980 $5.65 Million
Q3 2023

Nov 14, 2023

SELL
$194.44 - $217.61 $66,109 - $73,987
-340 Reduced 1.55%
21,549 $4.22 Million
Q2 2023

Aug 10, 2023

SELL
$183.71 - $210.25 $156,888 - $179,553
-854 Reduced 3.76%
21,889 $4.62 Million
Q1 2023

May 12, 2023

SELL
$191.89 - $259.92 $112,639 - $152,573
-587 Reduced 2.52%
22,743 $4.59 Million
Q4 2022

Feb 10, 2023

BUY
$197.11 - $250.07 $64,257 - $81,522
326 Added 1.42%
23,330 $5.1 Million
Q3 2022

Nov 01, 2022

SELL
$182.44 - $250.54 $124,424 - $170,868
-682 Reduced 2.88%
23,004 $4.53 Million
Q2 2022

Aug 12, 2022

BUY
$204.13 - $302.4 $4.84 Million - $7.16 Million
23,686 New
23,686 $5.08 Million
Q2 2022

Aug 09, 2022

SELL
$204.13 - $302.4 $5.11 Million - $7.57 Million
-25,049 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$255.51 - $362.11 $27,339 - $38,745
107 Added 0.43%
25,049 $7.47 Million
Q4 2021

Feb 14, 2022

BUY
$351.38 - $448.68 $777,252 - $992,480
2,212 Added 9.73%
24,942 $9.38 Million
Q3 2021

Nov 15, 2021

BUY
$372.64 - $458.3 $3.28 Million - $4.03 Million
8,798 Added 63.15%
22,730 $9.44 Million
Q2 2021

Aug 11, 2021

SELL
$294.17 - $371.65 $1.66 Million - $2.09 Million
-5,635 Reduced 28.8%
13,932 $5.15 Million
Q1 2021

May 17, 2021

SELL
$249.67 - $299.48 $1.5 Million - $1.8 Million
-6,021 Reduced 23.53%
19,567 $5.66 Million
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $625,818 - $712,135
-2,819 Reduced 9.92%
25,588 $6.39 Million
Q3 2020

Nov 17, 2020

SELL
$175.56 - $226.45 $13.8 Million - $17.9 Million
-78,857 Reduced 73.52%
28,407 $6.43 Million
Q3 2020

Nov 13, 2020

BUY
$175.56 - $226.45 $13.6 Million - $17.6 Million
77,717 Added 263.03%
107,264 $24.3 Million
Q2 2020

Aug 17, 2020

SELL
$118.84 - $189.72 $103,271 - $164,866
-869 Reduced 2.86%
29,547 $5.14 Million
Q1 2020

May 14, 2020

SELL
$98.9 - $178.34 $79,911 - $144,098
-808 Reduced 2.59%
30,416 $3.84 Million
Q4 2019

Feb 11, 2020

SELL
$126.05 - $152.76 $110,671 - $134,123
-878 Reduced 2.74%
31,224 $4.77 Million
Q3 2019

Oct 25, 2019

SELL
$125.07 - $143.67 $1.35 Million - $1.55 Million
-10,781 Reduced 25.14%
32,102 $4.25 Million
Q2 2019

Jul 31, 2019

SELL
$123.4 - $148.55 $265,680 - $319,828
-2,153 Reduced 4.78%
42,883 $0
Q1 2019

May 08, 2019

SELL
$104.82 - $146.73 $57,126 - $79,967
-545 Reduced 1.2%
45,036 $6.53 Million
Q4 2018

Feb 12, 2019

BUY
$105.09 - $137.23 $742,040 - $968,981
7,061 Added 18.33%
45,581 $4.93 Million
Q3 2018

Nov 13, 2018

BUY
$112.11 - $134.54 $5,605 - $6,727
50 Added 0.13%
38,520 $5.19 Million
Q2 2018

Aug 10, 2018

SELL
$102.37 - $117.25 $75,958 - $86,999
-742 Reduced 1.89%
38,470 $4.32 Million
Q1 2018

May 10, 2018

SELL
$98.19 - $115.2 $64,805 - $76,032
-660 Reduced 1.66%
39,212 $4.18 Million
Q4 2017

Feb 09, 2018

SELL
$100.43 - $118.09 $10,043 - $11,809
-100 Reduced 0.25%
39,872 $4.36 Million
Q3 2017

Nov 09, 2017

BUY
$96.72 - $109.26 $3.87 Million - $4.37 Million
39,972
39,972 $4.28 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.7B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.